Article Text

PDF
Randomised controlled trial
Success rates of abdominal sacrocolpopexy decrease over time, but with improved continence rates with concomitant urethropexy
  1. Elizabeth J Geller
  1. Division of Female Pelvic Medicine and Reconstructive Surgery, Obstetrics and Gynecology, University of North Carolina Hospital, Chapel Hill, North Carolina, USA
  1. Correspondence to : Dr Elizabeth J Geller, Division of Female Pelvic Medicine and Reconstructive Surgery, Obstetrics and Gynecology, University of North Carolina Hospital, CB 7570 Old Clinic, Chapel Hill, NC 27599-7570, USA; egeller{at}med.unc.edu

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMedWeb of Science

Context

The challenge of pelvic organ prolapse (POP) is to develop durable surgeries, including sacrocolpopexy. One must consider concomitant anti-incontinence procedures. This study by Nygaard and colleagues addresses the durability of sacrocolopexy, and also provides valuable data on the long-term efficacy of concurrent anti-incontinence surgery.

Methods

The extended colpopexy and urinary reduction efforts (eCARE) trial provides follow-up of the CARE trial.1 Women with advanced POP without baseline incontinence were randomised to receive abdominal sacrocolpopexy with or without urethropexy. The majority (215/231) were enrolled and 121 women (56%) completed a 7-year assessment. The outcomes included anatomic and symptomatic …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.